Koninklijke Ahold Delhaize N.V. (ADRNY)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 29, 2024	Dec 31, 2023	Jan 1, 2023	Jan 2, 2022	Jan 3, 2021
Market Capitalization	35,837	30,123	27,627	28,035	34,772	29,558
Market Cap Growth	20.18%	9.04%	-1.46%	-19.38%	17.64%	6.87%
Enterprise Value	53,871	45,409	44,547	45,554	50,694	43,708
Last Close Price	39.47	32.23	27.39	26.66	31.06	24.82
PE Ratio	18.33	16.38	13.34	10.30	13.61	17.32
PS Ratio	0.36	0.32	0.28	0.30	0.40	0.32
PB Ratio	2.14	1.87	1.69	1.70	2.23	1.95
P/TBV Ratio	28.33	14.20	14.23	11.76	32.15	27.91
P/FCF Ratio	8.32	7.36	6.20	7.25	9.87	6.57
P/OCF Ratio	5.23	4.64	3.87	4.29	5.59	3.82
EV/Sales Ratio	0.51	0.49	0.45	0.49	0.59	0.48
EV/EBITDA Ratio	7.09	8.57	7.83	7.52	8.99	6.96
EV/EBIT Ratio	13.32	12.78	11.83	10.91	13.15	9.84
EV/FCF Ratio	12.51	11.09	10.00	11.78	14.39	9.71
Debt / Equity Ratio	1.32	1.32	1.21	1.15	1.25	1.17
Debt / EBITDA Ratio	3.10	3.17	2.74	2.53	2.81	2.34
Debt / FCF Ratio	5.12	5.18	4.41	4.88	5.52	3.95
Asset Turnover	1.77	1.79	1.84	1.85	1.75	1.82
Inventory Turnover	13.84	13.98	14.11	15.28	15.75	16.43
Quick Ratio	0.41	0.52	0.39	0.38	0.38	0.41
Current Ratio	0.75	0.84	0.73	0.72	0.68	0.70
Return on Equity (ROE)	11.77%	11.68%	12.43%	17.48%	17.18%	10.54%
Return on Assets (ROA)	4.25%	4.27%	4.42%	5.18%	4.90%	5.53%
Return on Capital (ROIC)	6.07%	6.23%	6.49%	7.65%	7.33%	8.04%
Return on Capital Employed (ROCE)	10.20%	9.90%	10.60%	11.70%	10.80%	13.00%
Earnings Yield	5.46%	6.11%	7.50%	9.71%	7.35%	5.77%
FCF Yield	12.02%	13.59%	16.13%	13.80%	10.13%	15.22%
Dividend Yield	2.64%	3.79%	4.44%	4.21%	3.48%	4.43%
Payout Ratio	57.45%	58.79%	55.71%	38.45%	38.11%	73.44%
Buyback Yield / Dilution	3.34%	3.42%	3.50%	3.19%	3.55%	3.60%
Total Shareholder Return	5.98%	7.20%	7.94%	7.40%	7.02%	8.03%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.